» Articles » PMID: 10935503

Tumoral Environment Triggers Transcript Anomalies in Established Tumors: Induction of Altered Gene Expression and of Aberrant, Truncated and B2 Repeat-containing Gene Transcripts

Overview
Journal Neoplasia
Publisher Elsevier
Specialty Oncology
Date 2000 Aug 10
PMID 10935503
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to eugenetic changes, cancerous cells exhibit extensive modifications in the expression levels of a variety of genes. The phenotypic switch observed after inoculation of T lymphoma cells into syngenic mice illustrates the active participation of tumoral environment in the induction of an aberrant gene expression pattern. To further substantiate this contribution, we performed polymerase chain reaction (PCR)-based subtraction suppression hybridization (SSH) to identify genes that are differentially expressed in tumor-derived EL4/13.3 cells compared to the same cells isolated from cultures. Besides a number of unknown genes, the subtracted library contained several known genes that have been reported to be expressed at increased levels in tumors and/or to contribute to carcinogenesis. Apart from clones representing translated transcripts, the subtracted library also contained a high number of clones representing B2 repeat elements, viz. short interspersed repetitive elements that are transcribed by RNA polymerase III. Northern blotting confirmed the induction of B2 transcripts in tumor tissue and also revealed induction of chimeric, B2 repeat-containing mRNA. The appearance of chimeric transcripts was accompanied by aberrant, shorter-than-full-length transcripts, specifically from upregulated genes. Accordingly, in addition to altered gene expression, tumoral environmental triggers constitute a potent mechanism to create an epigenetic diversity in cancers by inducing extensive transcript anomalies.

References
1.
Zusman T, Gohar O, Eliassi H, Avivi Y, Lisansky E, Sautes C . The murine Fc-gamma (Fc gamma) receptor type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells. Int J Cancer. 1996; 65(2):221-9. DOI: 10.1002/(SICI)1097-0215(19960117)65:2<221::AID-IJC16>3.0.CO;2-G. View

2.
Oberbaumer I . Retroposons do jump: a B2 element recently integrated in an 18S rDNA gene. Nucleic Acids Res. 1992; 20(4):671-7. PMC: 312003. DOI: 10.1093/nar/20.4.671. View

3.
Sutherland R . Tumor hypoxia and gene expression--implications for malignant progression and therapy. Acta Oncol. 1998; 37(6):567-74. DOI: 10.1080/028418698430278. View

4.
Larsson S, Charlieu J, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A . Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell. 1995; 81(3):391-401. DOI: 10.1016/0092-8674(95)90392-5. View

5.
Desmedt M, Rottiers P, Dooms H, Fiers W, Grooten J . Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol. 1998; 160(11):5300-8. View